Schlosser Mario sold $25.9M of OSCR
Schlosser Mario sold 880,000 shares of Oscar Health, Inc. (OSCR) at an average of $29.38 ($28.95–$30.09, $25.85M total) across 3 trades on 2026-06-23 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The key new information is the disclosed sale size, execution window (2026-06-23), and the confirmation that it was under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor OSCR for any follow-on insider activity, but the 10b5-1 structure typically dampens interpretive impact.
What to watch
The filing does not indicate whether other insiders or institutions are buying/selling, nor does it provide any new operational or financial guidance.
Background
This is an SEC Form 4 insider transaction disclosure for Oscar Health, Inc. (OSCR).
Ticker impact
Oscar Health director Mario Schlosser sold 880,000 shares in open-market transactions totaling about $25.85M under a 10b5-1 plan.
Low likelihood of a sustained price move solely from this filing; any impact is likely short-lived sentiment drift.
Form 4 discloses transaction size and timing (6/23) and confirms it was executed under a pre-arranged 10b5-1 plan, which typically limits interpretive weight versus discretionary selling.
Market effects
Limited read-across to the digital health/insurtech peer group; this is company-specific insider activity.
None.
None.
Counterpoint
Because the trades were executed under a 10b5-1 plan, the sale may reflect routine liquidity needs rather than bearish expectations.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider sale; director Mario Schlosser sold 880,000 shares.
- insiderMario Schlosser
Director who executed open-market sales totaling ~$25.85M under a 10b5-1 plan.
